Clinical Trials
clinical trials
A Phase I clinical trial of GL-ONC1 is currently underway in the United Kingdom. Additional clinical trials are in regulatory preparation and/or submission stages. Any information regarding patient selection and participation in any clinical trial involving Genelux products will be available only from the clinical institutions conducting the trial. Study summaries and patient selection criteria will be posted on www.clinicaltrials.gov, the public registry managed by the National Institutes of Health.
Click here for a listing of clinical trials associated with Genelux Corporation.